Credit Agricole
NKTR icon

Credit Agricole’s Nektar Therapeutics NKTR Stock Holding History

Credit Agricole’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,362
Closed -$351K – 717
2021
Q2 		$351K Buy
1,362
+213
+19% +$58.9K 0.01% 314
2021
Q1 		$345K Buy
1,149
+980
+580% +$305K 0.01% 291
2020
Q4 		$43K Buy
169
+100
+145% +$25.8K ﹤0.01% 411
2020
Q3 		$17K Hold
69
– – ﹤0.01% 424
2020
Q2 		$24K Buy
+69
New +$21.5K ﹤0.01% 365
2016
Q1 		– Sell
-1,333
Closed -$337K – 1347
2015
Q4 		$337K Buy
+1,333
New +$274K ﹤0.01% 1221

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Credit Agricole's NKTR Position: Q3 2021 in Review

Credit Agricole sold out of Nektar Therapeutics (NKTR) in Q3 2021, closing a stake of 1,362 shares — an estimated $351K sold.

Credit Agricole first reported a position in NKTR in Q4 2015 and held it in 6 quarters. The position peaked at $351K in Q2 2021. 240 funds tracked by Wall St. Rank hold NKTR as of Q3 2021.

  • Credit Agricole reported no remaining Nektar Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Credit Agricole sold 1,362 Nektar Therapeutics shares in Q3 2021, an estimated $351K.
  • Credit Agricole first reported a position in Nektar Therapeutics in Q4 2015 and held it in 6 quarters.
  • Credit Agricole's Nektar Therapeutics position peaked at $351K in Q2 2021.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2021.

Based on Credit Agricole's 13F filing for Q3 2021, filed 15 Nov 2021.